Invest in Medicinal Cannabis With Orange River Wealth

London-based boutique investment partnership Orange River Wealth looks at why the power of medicinal marijuana is going from strength to strength.  

What is Medicinal Cannabis? 

Medicinal cannabis works by altering pain perceptions pathways in the brain.  

Different to recreational marijuana, cannabis plants contain more than 100 different compounds called cannabinoids. These act on receptors within the brain and influence mood, memory, sleep, the immune system and appetite.  

The most recognised cannabinoids are cannabidiol (CBD) and tetrahydrocannabinol (THC) - two natural compounds with different impacts and effects.  

THC is commonly associated with the psychoactive high from smoking or ingesting marijuana, while CBD is the compound responsible for the majority of medical benefits surrounding medical-grade cannabis. 

How is Medicinal Cannabis Grown?  

Medical cannabis agribusiness is intensively monitored and its horticultural best practices meet stringent regulatory requirements while maximising profit by via calibre and yield.  

Horticultural methodology is a highly sophisticated commercial activity combining microbiology with plant science and analytical chemistry designed to prevent misuse and ensure safety, consistency and quality.

Moreover, as scientific research and evidence-based efficacy develop, the clinical scientific perspective opens more opportunities for collaboration. 

Medicinal Cannabis Is A Market On The Rise

The market’s exponential growth is welcome news given that chronic pain affects more than and estimated 26 million people in the UK. 

Public Health England research also shows that opioid painkilling prescriptions have risen by 22 per cent over the past decade to 40 million prescriptions a year. However, unlike conventional painkilling medication, medicinal cannabis isn't addictive. 

Taken in different ways and available in oils, capsules, teas and tinctures, NHS doctors are now legally issuing prescriptions for cannabis-based medicines in order to successfully treat conditions including Alzheimer's, Parkinson’s, Crohn's disease, arthritis and neuropathic pain.  

Cannabis-based medicines are also used to treat epilepsy, multiple sclerosis and muscle spasms as well as cancer-related symptoms, severe and chronic pain and common mental health issues such as anxiety, depression and insomnia.  

The industry is on an explosively upward trajectory, and medicinal cannabis looks set to become the next largest global commodity forecasted to be worth US$62.7 billion by 2024.  

Medicinal Cannabis Investment Opportunities 

Headquartered in London’s Mayfair, Orange River Wealth is exploiting medicinal cannabis’ burgeoning opportunity and rising to the challenge of a new era of investment. 

The company has merged its meticulous research with corporate oversight to create opportunities within this emerging market.   

After reaching an agreement to purchase 49 per cent of a fully licensed, operational medicinal cannabis facility in South Africa, via its wholly-owned subsidiary, Orange River Capital, the boutique investment partnership is collaborating to provide capital funding to expand its current production capacity by over 300 per cent.  

This would see the facility expand operations from three tonnes per annum to up to 146 tonnes and move from a national operation to an international one creating a global brand in an emerging market. 

With this growth strategy applied alongside a deliverable return throughout the lifecycle, Orange River Wealth have created an exciting and innovative investment opportunity for qualified, professional and sophisticated investors.  

If you are interested to find out more on this investment opportunity and its eligibility criteria, visit orangeriverwealth.com